Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Therapeutic management of type 1 diabetes before and during pregnancy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  1. Pharmacotherapeutic considerations in women with multiple sclerosis

    Publikation: Bidrag til tidsskriftReviewpeer review

  2. The efficacy and safety of exenatide once weekly in patients with type 2 diabetes

    Publikation: Bidrag til tidsskriftReviewpeer review

  3. Treatment of adult short bowel syndrome patients with teduglutide

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Irinotecan and bevacizumab in recurrent glioblastoma multiforme

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Treating tension-type headache -- an expert opinion

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Biomarkers and Their Relation to Cardiac Function Late After Peripartum Cardiomyopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Impact of Lean Body Mass and Insulin Sensitivity on the IGF-1-Bone Mass Axis in Adolescence: the EPICOM study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Genome-wide association study of circulating levels of glucagon during an oral glucose tolerance test

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Introduction: Pregnancy increases the risks of adverse outcomes for mother and infant in women with type 1 diabetes. Obtaining and maintaining adequate glycemic control during pregnancy is crucial for optimizing outcomes. Areas covered: The importance of prepregnancy planning and treatment during pregnancy is reviewed. The use of insulin analogues and antihypertensive drugs in diabetic pregnancy are in focus. The reader is presented with evidence discussing the importance of prepregnancy counseling and treatment during pregnancy in women with type 1 diabetes. Expert opinion: Tight glycemic control before and during pregnancy is crucial and the prevalence of severe hypoglycemia during pregnancy needs to be reduced. Rapid-acting insulin analogues are regarded as safe to use in pregnancy and studies on long-acting insulin analogues are in the pipeline. Supplementation with folic acid may reduce the risk of malformations. Screening for diabetic retinopathy, diabetic nephropathy and thyroid dysfunction is important, and indications for antihypertensive treatment and treatment of thyroid dysfunction need to be in focus before and during pregnancy.
OriginalsprogEngelsk
TidsskriftExpert Opinion on Pharmacotherapy
Vol/bind12
Udgave nummer5
Sider (fra-til)779-86
Antal sider8
DOI
StatusUdgivet - 1 apr. 2011

ID: 31041456